{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
EXACT Sciences Corp.
EXACT Sciences Forms Golden Cross, Signaling Potential Bullish Breakout Ahead
EXACT Sciences Corp. has recently achieved a Golden Cross, signaling a potential shift in market momentum. Current technical indicators suggest a bullish outlook, with positive trends in moving averages and Bollinger Bands. Despite a challenging year, the stock has shown resilience with recent gains, reflecting improved market sentiment.
EXACT Sciences Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics
EXACT Sciences Corp., a small-cap in the Pharmaceuticals & Biotechnology sector, has seen its stock price rise slightly to $57.63. The stock has experienced notable volatility over the past year, with mixed technical indicators suggesting varying market sentiments. Its performance has been inconsistent compared to the S&P 500.
Is EXACT Sciences Corp. technically bullish or bearish?
As of October 3, 2025, EXACT Sciences Corp. shows a neutral technical trend with mixed signals, including bullish weekly MACD and Bollinger Bands, but a mildly bearish daily moving average, and while it has outperformed the S&P 500 recently, it has underperformed over the past year.
Is EXACT Sciences Corp. technically bullish or bearish?
As of October 3, 2025, EXACT Sciences Corp. shows a neutral trend with mixed signals, including bullish weekly MACD and Bollinger Bands, but mildly bearish daily moving averages, while outperforming the S&P 500 in the short term but underperforming over the past year, suggesting a cautious investment approach.
Is EXACT Sciences Corp. technically bullish or bearish?
As of October 3, 2025, EXACT Sciences Corp. shows a neutral trend with mixed indicators, including bullish weekly and monthly MACD and Bollinger Bands, but mildly bearish daily moving averages, while outperforming the S&P 500 in the short term but underperforming over the longer term.
Is EXACT Sciences Corp. technically bullish or bearish?
As of September 12, 2025, EXACT Sciences Corp. shows a mildly bearish trend due to daily moving averages, despite mixed signals from weekly and monthly indicators, and has significantly underperformed the S&P 500 with a 1-year return of -22.57% compared to the index's 17.14%.
EXACT Sciences Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics
EXACT Sciences Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has seen its stock price fluctuate significantly over the past year. Recent evaluations reflect mixed technical indicators, and the company has underperformed compared to the S&P 500 in both short and long-term returns.
Is EXACT Sciences Corp. technically bullish or bearish?
As of May 9, 2024, the market trend has shifted to a moderate bearish stance, indicated by bearish momentum in the MACD and Bollinger Bands on the monthly timeframe, despite a bullish weekly KST.
Who are in the management team of EXACT Sciences Corp.?
As of March 2022, the management team of EXACT Sciences Corp. includes Kevin Conroy as Chairman, President, and CEO, and Shacey Petrovic as a Director, along with Independent Directors Thomas Carey, James Doyle, Pierre Jacquet, and Daniel Levangie.
What does EXACT Sciences Corp. do?
Exact Sciences Corporation is a mid-cap molecular diagnostics company focused on early cancer detection and prevention. As of March 2025, it reported net sales of $707 million and a net loss of $101 million.
How big is EXACT Sciences Corp.?
As of Jun 18, EXACT Sciences Corp. has a market capitalization of $9.91 billion, with net sales of $2.83 billion and a net profit of -$1.02 billion over the last four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
